疑似脓毒症患者急诊抗生素过度治疗及相关危害的频率:一项回顾性队列研究
该回顾性队列研究纳入7家医院急诊科2019至2022年600例因疑似脓毒症接受抗MRSA和/或抗假单胞菌β-内酰胺类抗生素治疗的成人患者,评估事后感染可能性、抗生素是否过宽及90天内抗生素相关并发症。结果显示31.5%患者可能无细菌感染,有感染者中79.1% retrospectively抗生素过宽,17.3%发生抗生素相关并发症。
要点
- 600例疑似脓毒症患者中31.5%可能无细菌感染(18.3%可能性低,13.2%确定无感染)。
- 确诊/很可能细菌感染患者中79.1%(325/411) retrospectively抗生素覆盖过宽。
- 17.3%(104/600)在90天内出现抗生素相关并发症,最常见为耐药菌感染或定植(8.0%)。
核心结论
- 600例因疑似脓毒症接受广谱抗生素治疗的患者中,约1/3最可能无细菌感染,有细菌感染者中4/5 retrospectively治疗方案比必要更广,1/6出现抗生素相关并发症。
研究设计与样本
- 回顾性队列研究,纳入7家医院急诊科2019至2022年600例接受抗MRSA和/或抗假单胞菌β-内酰胺类抗生素治疗的疑似脓毒症成人患者,查阅病历评估事后感染可能性、更窄抗生素是否足够及可能抗生素相关并发症,采用广义估计方程分析感染可能性与住院死亡率的关系。
主要发现
- 600例中411例(68.5%)有确定(48.0%)或很可能(20.5%)细菌感染,189例(31.5%)有可能性但较低(18.3%)或确定无(13.2%)细菌感染。
- 确定/很可能细菌感染患者中325/411(79.1%) retrospectively接受过宽抗生素治疗。
- 600例中104例(17.3%)在90天内出现潜在抗生素相关并发症,最常见为新发对一线药物耐药微生物感染或定植(48/600[8.0%])。
- 可能性低/确定无细菌感染患者较确定/很可能细菌感染患者死亡率更高(9.0% vs 4.9%;调整OR 2.25[95%CI 1.70-2.98])。
- 两组抗生素相关并发症发生率相似(14.8% vs 18.5%;调整OR 0.79[95%CI 0.60-1.05])。
关键数值与推荐
- 细菌感染可能性分类:确定48.0%、很可能20.5%、可能性低18.3%、确定无13.2%。
- 抗生素过宽定义:事后回顾更窄抗生素方案本可足够,见于确诊/很可能感染患者的79.1%。
- 抗生素相关并发症:90天内发生,总体17.3%,耐药菌感染或定植8.0%。
- 死亡率比较:可能性低/确定无细菌感染组9.0% vs 确定/很可能感染组4.9%,调整OR 2.25(95%CI 1.70-2.98)。
- 并发症比较:可能性低/确定无感染组14.8% vs 确定/很可能感染组18.5%,调整OR 0.79(95%CI 0.60-1.05)。
临床怎么用
- 原文未根据研究结果给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Treatment guidelines recommend rapidly treating all patients with suspected sepsis with broad-spectrum antibiotics. This may contribute to antibiotic overuse. We quantified the incidence of antibiotic overtreatment and possible antibiotic-associated harms among patients with suspected sepsis. METHODS: We reviewed the medical records of 600 adults treated for suspected sepsis with anti-methicillin-resistant Staphylococcus aureus and/or antipseudomonal β-lactam antibiotics in the emergency departments of 7 hospitals, 2019-2022, to assess their post hoc likelihood of infection, whether narrower antibiotics would have sufficed in retrospect, and possible antibiotic-associated complications. We used generalized estimating equations to assess associations between likelihood of infection and hospital mortality. RESULTS: Of 600 patients, 411 (68.5%) had definite (48.0%) or probable (20.5%) bacterial infection and 189 (31.5%) had possible but less likely (18.3%) or definitely no (13.2%) bacterial infection. Among patients with definite/probable bacterial infection, 325 of 411 (79.1%) received antibiotics that were overly broad in retrospect. Potential antibiotic-associated complications developed in 104 of 600 (17.3%) patients within 90 days, most commonly new infection or colonization with organisms resistant to first-line agents (48/600 [8.0%]). Mortality was higher for patients with less likely/definitely no bacterial infection versus definite/probable bacterial infections (9.0% vs 4.9%; adjusted odds ratio [aOR], 2.25 [95% confidence interval{CI}, 1.70-2.98]), but antibiotic-associated complication rates were similar (14.8% vs 18.5%; aOR, 0.79 [95% CI, .60-1.05]). CONCLUSIONS: Among 600 patients treated with broad-spectrum antibiotics for possible sepsis, 1 in 3 most likely did not have a bacterial infection, 4 in 5 of those with bacterial infections were treated with regimens that were broader than necessary in retrospect, and 1 in 6 developed antibiotic-associated complications.
引用
- Shappell CN, Yu T, Klompas M, et al. Frequency of Antibiotic Overtreatment and Associated Harms in Patients Presenting With Suspected Sepsis to the Emergency Department: A Retrospective Cohort Study. Clin Infect Dis. 2025. PMID: 40231968. doi:10.1093/cid/ciaf118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。